1. Introduction

Genetically Modified (GM) crops are agricultural plants whose genetic material has been altered through genetic engineering to introduce particular characteristics, such as insect resistance, herbicide tolerance, disease resistance, improved nutritional value or increased productivity.

Examples include:

Bt cotton – insect-resistant cotton.

Bt brinjal – genetically modified eggplant.

GM mustard (DMH-11) – developed to facilitate hybrid seed production.

Herbicide-tolerant soybean – designed to tolerate particular herbicides.

Golden Rice – developed to produce beta-carotene.

Although GM technology offers potential agricultural and economic benefits, its commercial use raises important legal concerns involving environmental protection, food safety, biodiversity, farmers' rights, intellectual property and public participation.

Restrictions on GM crop commercialization refer to legal and administrative controls imposed by governments on the approval, production, cultivation, marketing, import, export and distribution of genetically modified agricultural products.

The central legal question is whether the potential benefits of GM crops justify their commercial release when scientific uncertainty or environmental risks remain.

2. Legal Framework Governing GM Crop Commercialization in India

India regulates GM crops through environmental, agricultural, food-safety and biotechnology legislation.

A. Environment (Protection) Act, 1986

The Environment (Protection) Act, 1986 provides the principal statutory foundation for regulating genetically modified organisms in India.

Under Section 3, the Central Government has extensive powers to take measures to protect and improve environmental quality.

Section 6 authorizes the government to make rules regulating activities involving hazardous substances.

Section 25 provides rule-making powers.

These provisions support restrictions on the manufacture, use, import, export and environmental release of genetically modified organisms.

B. Environment (Protection) Rules, 1986

The Environment (Protection) Rules provide the regulatory framework under which biotechnology-related restrictions are implemented.

The most important provisions are found in the:

Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms/Genetically Engineered Organisms or Cells, 1989.

These rules regulate:

Genetic engineering experiments.

Laboratory research.

Field trials.

Environmental release.

Commercial production.

Import and export of GM organisms.

Handling and storage of genetically modified materials.

Commercialization without the necessary regulatory authorization may attract legal consequences.

C. Food Safety and Standards Act, 2006

The Food Safety and Standards Act, 2006 regulates food safety in India.

GM food products may raise questions concerning:

Food safety assessment.

Toxicological effects.

Allergenicity.

Nutritional composition.

Packaging and labelling.

Consumer information.

Traceability.

Section 23 is particularly relevant because it regulates packaging and labelling of food products.

The Act provides an additional regulatory layer where GM crops or their derivatives enter the food supply chain.

D. Biological Diversity Act, 2002

The Biological Diversity Act, 2002 is relevant when GM crop research and commercialization involve biological resources and associated traditional knowledge.

The legislation addresses:

Access to biological resources.

Conservation of biodiversity.

Sustainable use.

Benefit-sharing.

Protection of traditional knowledge.

Commercial biotechnology activities must comply with applicable biodiversity requirements.

E. Seed Legislation

The Seeds Act, 1966 and Seeds Rules, 1968 regulate seed quality, certification and marketing.

GM seed commercialization may also require compliance with applicable seed-related requirements, including notified variety and quality standards.

The environmental approval of a GM organism and its eligibility for commercial seed marketing are legally distinct questions.

3. Major Restrictions on GM Crop Commercialization

A. Mandatory Biosafety Approval

One of the most important restrictions is the requirement for prior regulatory approval.

A biotechnology company cannot assume that successful laboratory development automatically authorizes commercial cultivation.

The applicant may have to establish:

Genetic stability.

Environmental safety.

Toxicological safety.

Allergenicity assessment.

Potential effects on non-target organisms.

Gene-flow risks.

Effects on biodiversity.

Agricultural suitability.

The Genetic Engineering Appraisal Committee (GEAC), functioning under the Ministry of Environment, Forest and Climate Change, plays a central role in environmental appraisal.

The regulatory system also involves institutional biosafety committees and other specialized authorities.

B. Restrictions on Environmental Release

Commercialization involves introducing GM crops into agricultural ecosystems.

This can create concerns about:

Cross-pollination.

Gene flow into conventional crops.

Contamination of non-GM agricultural varieties.

Effects on wild relatives.

Development of herbicide-resistant weeds.

Changes in pest populations.

Possible impacts on soil microorganisms.

Regulators may consequently impose geographical restrictions, isolation distances, monitoring obligations and other environmental safeguards.

C. Restrictions on Herbicide-Tolerant Crops

Herbicide-tolerant crops are particularly controversial.

These crops are engineered to tolerate particular herbicides, allowing farmers to control weeds without destroying the cultivated crop.

However, legal concerns include:

Increased herbicide use.

Development of herbicide-resistant weeds.

Environmental contamination.

Effects on biodiversity.

Risks to agricultural workers.

Potential socioeconomic consequences for farmers.

The legal issue is not simply whether the crop is genetically modified, but whether its intended agricultural use creates additional environmental risks.

D. Restrictions for Biodiversity Protection

India possesses substantial agricultural biodiversity, including traditional crop varieties.

Commercial GM cultivation may create concerns about genetic contamination and the displacement of indigenous varieties.

Regulatory authorities may therefore require:

Gene-flow assessment.

Conservation strategies.

Monitoring of neighbouring agricultural areas.

Protection of traditional varieties.

Special restrictions in ecologically sensitive areas.

E. Consumer Protection and Labelling

Consumers have an interest in knowing whether food products contain genetically modified ingredients.

Labelling requirements promote transparency and informed purchasing decisions.

Legal issues include:

Misleading food advertisements.

Failure to disclose relevant product information.

Incorrect ingredient declarations.

Consumer access to safety information.

The Supreme Court's 2024 decision in Gene Campaign v. Union of India specifically addressed compliance with Section 23 of the Food Safety and Standards Act concerning imported GM food, particularly GM edible oil.

4. Important Judicial Decisions and Case Laws

The Indian judiciary has played an important role in establishing legal safeguards for GM crop research and commercialization.

Case 1: Aruna Rodrigues v. Union of India (2012)

Important Indian Supreme Court decision

Citation: (2012) 5 SCC 331.

Court: Supreme Court of India.

Background:

The petitioners raised concerns about the environmental and public-health consequences of releasing genetically modified organisms into the environment.

They questioned whether existing biosafety assessment procedures were sufficiently rigorous.

The dispute involved the regulation of field trials and the possibility of imposing restrictions on GM crops.

Legal issues:

Whether GM field trials required strict regulatory supervision.

Whether environmental safeguards were adequate.

Whether a complete ban on GM field trials was necessary.

Whether independent scientific assessment was required.

Decision and directions:

The Supreme Court constituted a Technical Expert Committee to examine biosafety issues.

Earlier judicial directions had required GEAC approval for field trials. The Court also referred to safeguards such as a 200-metre isolation distance and a 0.01% level-of-detection protocol.

The government had separately imposed a moratorium on Bt brinjal in February 2010.

Legal significance:

This case established the importance of scientific assessment, regulatory supervision and environmental safeguards before GM organisms are released.

It also demonstrated that field-trial permission and commercial approval are separate regulatory stages.

Source:

Indian Kanoon+1

Case 2: Dr. K. Thiruthanikachalam v. Union of India (2010)

Court: Supreme Court of India.

Background:

The case concerned the government's decision regarding the commercialization of Bt brinjal.

On 9 February 2010, the Ministry of Environment and Forests announced a moratorium on the environmental release of Bt brinjal.

The decision followed concerns about scientific uncertainty, public opposition and unanswered biosafety questions.

Legal principle:

The government adopted a precautionary approach because sufficient scientific consensus regarding long-term safety had not been established.

The moratorium was intended to remain until independent scientific studies established safety to the satisfaction of the relevant authorities and public stakeholders.

Legal significance:

The case illustrates that regulatory approval at one stage does not necessarily create an unconditional right to commercialize a GM crop.

Public health, environmental safety and scientific uncertainty may justify withholding commercialization.

Source:

Indian Kanoon+1

Case 3: Gene Campaign v. Union of India (2024)

Major constitutional and environmental law decision

Citation: 2024 INSC 545.

Court: Supreme Court of India.

Date: 23 July 2024.

Background:

The case involved the government's conditional approval for environmental release of genetically modified mustard, known as Dhara Mustard Hybrid-11 (DMH-11).

The approval was challenged on grounds including:

Inadequate biosafety assessment.

Potential environmental consequences.

Herbicide-tolerance concerns.

Lack of adequate public consultation.

Failure to consider expert committee recommendations.

Possible violation of Article 21 of the Constitution.

Judgment:

The two judges delivered separate opinions, resulting in a split verdict on important issues.

Justice B.V. Nagarathna's opinion:

Justice Nagarathna considered the approval legally defective because important environmental and health-related questions had not been adequately addressed.

She emphasized the need to examine potential effects on human, animal and plant health, including whether DMH-11 should be treated as a herbicide-tolerant crop.

She considered the approval inconsistent with the precautionary principle.

Justice Sanjay Karol's opinion:

Justice Karol took a different position on the challenge to the approval.

He considered the issue of banning herbicide-tolerant crops to be a matter of public policy and did not find sufficient grounds to invalidate the conditional approval.

He emphasized scientific evaluation, appropriate safeguards and continued monitoring.

Directions agreed upon by the Bench:

The Court directed the Union Government to:

Develop a national policy concerning GM crops.

Consult agricultural experts, biotechnology specialists, farmers and State Governments.

Ensure appropriate verification of experts participating in regulatory decisions.

Address conflicts of interest.

Improve transparency in regulatory decision-making.

Ensure compliance with applicable food packaging and labelling requirements.

The Court also recognized that judicial review of governmental decisions concerning GM organisms is permissible.

Legal significance:

This is one of the most important Indian judgments on restrictions governing GM crop commercialization.

It establishes that regulatory approvals must remain open to judicial scrutiny and that environmental decisions should be supported by transparent scientific reasoning.

Importantly, the two separate opinions should not be presented as a single majority ruling invalidating or upholding the DMH-11 approval.

Source:

Indian Kanoon+2

Case 4: Confédération Paysanne v. Premier Ministre (2018)

Citation: Case C-528/16.

Court: Court of Justice of the European Union.

Background:

The dispute concerned plants developed through newer techniques of mutagenesis.

The question was whether such plants could fall within the European Union's GMO regulatory framework.

Decision:

The Court held that organisms obtained through newer mutagenesis techniques generally fall within the definition of genetically modified organisms under Directive 2001/18/EC.

They cannot automatically benefit from exemptions applicable to conventional mutagenesis techniques with a long history of safe use.

Legal significance:

The decision reinforced the importance of regulatory scrutiny based on the applicable statutory definition of GMOs.

It also demonstrated that technological developments cannot automatically escape biosafety requirements.

Source:

EUR-Lex+1

Case 5: Monsanto Co. v. Geertson Seed Farms (2010)

Citation: 561 U.S. 139 (2010).

Court: Supreme Court of the United States.

Background:

The dispute involved genetically engineered Roundup Ready alfalfa.

The United States Department of Agriculture had granted non-regulated status to the crop without completing the environmental impact statement required under the National Environmental Policy Act (NEPA).

Conventional farmers and environmental organizations challenged the decision.

Decision:

The Supreme Court recognized that the regulatory decision had violated NEPA.

However, it rejected the lower court's broad nationwide injunction against almost all planting of the crop.

It held that an injunction must satisfy the applicable equitable requirements and cannot automatically follow from every procedural environmental-law violation.

Legal significance:

The judgment demonstrates that commercialization decisions may be challenged when environmental assessment procedures are defective.

It also establishes that the scope of judicial restrictions must be proportionate to the legal violation.

Source:

Justia U.S. Supreme Court Center+1

5. International Legal Framework

GM crop commercialization is also influenced by international environmental and trade agreements.

A. Cartagena Protocol on Biosafety, 2000

The Cartagena Protocol is an important international instrument governing the safe handling, transport and use of living modified organisms.

Its objectives include:

Protection of biological diversity.

Consideration of risks to human health.

Regulation of transboundary movement.

Risk assessment.

Risk management.

Advance informed agreement for specified movements.

The Protocol recognizes the importance of precaution in biosafety decision-making.

It allows countries to impose appropriate safeguards when scientific uncertainty exists.

B. Convention on Biological Diversity, 1992

The Convention on Biological Diversity promotes:

Conservation of biodiversity.

Sustainable use of biological resources.

Fair and equitable benefit-sharing.

GM crop commercialization must be considered alongside these environmental objectives.

C. WTO Agreement on Sanitary and Phytosanitary Measures

The WTO SPS Agreement regulates measures adopted to protect human, animal and plant health.

Countries may impose restrictions on GM food and agricultural products where the measures are supported by appropriate scientific evidence and comply with international trade obligations.

Article 5.7 permits provisional measures in situations involving insufficient scientific evidence, subject to specified requirements, including efforts to obtain additional information and review the measure within a reasonable period.

Therefore, biosafety restrictions must balance environmental protection with international trade obligations.

6. Principal Grounds for Restricting Commercialization

7. Constitutional Dimensions in India

Restrictions on GM crop commercialization also involve constitutional principles.

Article 21 – Right to Life

The Supreme Court has interpreted Article 21 to include the right to a clean and healthy environment.

Environmental risks associated with GM crops may therefore raise constitutional questions.

Article 48A – Environmental Protection

The State has a constitutional responsibility to protect and improve the environment and safeguard forests and wildlife.

Article 51A(g) – Fundamental Duty

Citizens have a constitutional duty to protect and improve the natural environment.

Article 14 – Equality Before Law

Regulatory decisions must not be arbitrary, discriminatory or based on undisclosed conflicts of interest.

Article 19(1)(g) – Freedom of Trade and Occupation

Biotechnology companies and agricultural businesses may invoke commercial freedoms.

However, reasonable restrictions can be imposed in the public interest under Article 19(6).

Thus, commercial freedom does not create an unconditional entitlement to market genetically modified agricultural products.

8. Liability for Unauthorized GM Crop Commercialization

Unauthorized commercialization can create different forms of legal liability.

A. Environmental liability

A company responsible for unauthorized environmental release may face regulatory action, restoration obligations and other applicable environmental consequences.

B. Civil liability

Affected farmers or other persons may seek compensation where they establish a legally recognized cause of action and resulting loss.

C. Criminal liability

Violations of applicable statutory requirements may attract criminal consequences where the relevant legislation provides for them.

D. Administrative liability

Authorities may suspend approvals, impose conditions, restrict distribution or require corrective measures.

E. Consumer protection liability

Misleading claims or violations of applicable food-labelling requirements may result in regulatory enforcement.

9. Major Legal Challenges

Despite the development of regulatory frameworks, several problems remain.

1. Scientific uncertainty: Long-term ecological effects may be difficult to predict.

2. Regulatory independence: Conflicts of interest may undermine public confidence in biosafety assessment.

3. Gene contamination: Genetic material may spread into neighbouring non-GM crops.

4. Farmer protection: Farmers may experience economic losses if GM cultivation affects conventional agricultural markets.

5. Corporate concentration: Control over patented biotechnology and seed markets can raise competition concerns.

6. Regulatory fragmentation: Environmental, food-safety and agricultural authorities may apply different approval standards.

7. Public participation: Farmers, consumers and local communities may not receive adequate opportunities to participate in important decisions.

8. International trade conflicts: Countries may disagree about the safety standards governing GM agricultural imports.

10. Suggestions for Legal and Regulatory Reform

A stronger GM crop commercialization framework should incorporate the following measures:

Independent scientific biosafety assessments.

Transparent publication of risk-assessment reports.

Mandatory disclosure of conflicts of interest.

Regular post-commercialization monitoring.

Effective gene-contamination prevention measures.

Clear rules concerning GM food labelling.

Compensation mechanisms for affected farmers.

Public consultation before major environmental approvals.

Periodic review of commercial authorizations.

Coordination between environmental, agricultural and food-safety authorities.

Regulation should be scientifically rigorous without automatically treating every genetically modified crop as equally hazardous.

11. Conclusion

Restrictions on GM crop commercialization represent an important intersection of biotechnology law, environmental law, constitutional law, agricultural regulation and consumer protection.

The Indian legal framework, particularly the Environment (Protection) Act, 1986 and the 1989 GMO Rules, provides mechanisms for regulating genetically modified organisms.

Judicial decisions such as Aruna Rodrigues v. Union of India (2012), Dr. K. Thiruthanikachalam v. Union of India (2010) and Gene Campaign v. Union of India (2024) demonstrate the importance of scientific assessment, regulatory transparency and environmental safeguards.

The 2024 Gene Campaign decision is particularly significant because it recognizes judicial review of GMO regulatory decisions and directs the government to develop a national GM-crop policy through stakeholder consultation.

Ultimately, the law must balance agricultural innovation and economic development against biodiversity conservation, food safety, farmers' interests and the constitutional right to a healthy environment.

The fundamental legal principle is that commercial approval of a GM crop must be supported by lawful authorization, scientifically defensible risk assessment and adequate environmental safeguards.

12. Important Case Laws – Quick Revision

Research note: The 2024 Indian Supreme Court decision is a split judgment on the substantive validity of DMH-11 approval. Its agreed directions, including formulation of a national policy, should be distinguished from the individual judges' differing conclusions.

For further legal research, the primary judgment is available here:

Gene Campaign v. Union of India – Supreme Court judgment (2024).

Aruna Rodrigues v. Union of India (2012).

Confédération Paysanne – CJEU judgment (2018).